Skip to Content

MELPHALAN 50 MG POWDER AND SOLVENT FOR SOLUTION FOR INJECTION/INFUSION

Active substance(s): MELPHALAN / MELPHALAN HYDROCHLORIDE / NO ACTIVES PRESENT

PDF options:  View Fullscreen   Download PDF

PDF Transcript



 
  
Package Leaflet: Information for the User

Melphalan 50 mg Powder
and Solvent for Solution for
Injection/Infusion.
melphalan
Read all of this leaflet carefully before you start using this medicine
Ě .HHSWKLVOHDIOHW Ě ,I\RXKDYHDQ\IXUWKHUTXHVWLRQVDERXW\RXULOOQHVVRU\RXUPHGLFLQHDVN
\RXUGRFWRURUQXUVH
Ě ,IDQ\RIWKHVLGHHIIHFWVJHWVHULRXVRULI\RXQRWLFHDQ\VLGHHIIHFWVQRW
OLVWHGLQWKLVOHDIOHWSOHDVHWHOO\RXUGRFWRUQXUVHRUSKDUPDFLVW
In this leaflet:
1 :KDW0HOSKDODQLVDQGZKDWLWLVXVHGIRU
2 %HIRUH\RXKDYH0HOSKDODQ
3 +RZWRKDYH0HOSKDODQ
4 3RVVLEOHVLGHHIIHFWV
5 +RZWRVWRUH0HOSKDODQ
6 )XUWKHULQIRUPDWLRQ
1 What Melphalan is and what it is used for
0HOSKDODQLQMHFWLRQFRQWDLQVDPHGLFLQHFDOOHGPHOSKDODQ7KLVEHORQJVWRD
JURXSRIPHGLFLQHVFDOOHGF\WRWR[LFV DOVRFDOOHGFKHPRWKHUDS\ 0HOSKDODQ
LVXVHGWRWUHDWFDQFHU,WZRUNVE\UHGXFLQJWKHQXPEHURIDEQRUPDOFHOOV
\RXUERG\PDNHV
0HOSKDODQLVXVHGIRU
Ě Multiple myeloma ĘDW\SHRIFDQFHUWKDWGHYHORSVIURPFHOOVLQWKH
ERQHPDUURZFDOOHGSODVPDFHOOV3ODVPDFHOOVKHOSWRILJKWLQIHFWLRQDQG
GLVHDVHE\SURGXFLQJDQWLERGLHV
Ě $GYDQFHGcancer of the ovaries
Ě Childhood neuroblastomaFDQFHURIWKHQHUYRXVV\VWHP
Ě Malignant melanoma ĘVNLQFDQFHU
Ě Soft tissue sarcoma ĘFDQFHURIWKHPXVFOHIDWILEURXVWLVVXHEORRG
YHVVHOVRURWKHUVXSSRUWLQJWLVVXHRIWKHERG\
$VN\RXUGRFWRULI\RXZRXOGOLNHPRUHH[SODQDWLRQDERXWWKHVHGLVHDVHV
2 Before you have Melphalan
Do not have Melphalan if:
Ě  LQJUHGLHQWVRI0HOSKDODQLQMHFWLRQ 6HHVHFWLRQ)XUWKHULQIRUPDWLRQ
'RQRWKDYH0HOSKDODQLIWKHDERYHDSSOLHVWR\RX,I\RXDUHQRWVXUHWDON
WR\RXUGRFWRURUQXUVHEHIRUHKDYLQJ0HOSKDODQ

Melphalan 50 mg Powder
and Solvent for Solution for
Injection/Infusion.
melphalan

Take special care with Melphalan
%HIRUH\RXXVH0HOSKDODQWHOO\RXUGRFWRURUQXUVHLI
Ě \RXKDYHKDGUDGLRWKHUDS\RUFKHPRWKHUDS\QRZRUUHFHQWO\
Ě \RXKDYHDNLGQH\SUREOHP
,I\RXDUHQRWVXUHLIDQ\RIWKHDERYHDSSO\WR\RXWDONWR\RXUGRFWRURU
QXUVHEHIRUHKDYLQJ0HOSKDODQ
Taking other medicines
3OHDVHWHOO\RXUGRFWRURUQXUVHLI\RXDUHWDNLQJRUKDYHUHFHQWO\WDNHQDQ\
RWKHUPHGLFLQHVLQFOXGLQJPHGLFLQHVREWDLQHGZLWKRXWDSUHVFULSWLRQ7KLV
LQFOXGHVKHUEDOPHGLFLQHV
,QSDUWLFXODUWHOO\RXUGRFWRURUQXUVHLI\RXDUHWDNLQJDQ\RIWKHIROORZLQJ
Ě RWKHUF\WRWR[LFGUXJV FKHPRWKHUDS\ 
Ě QDOLGL[LFDFLG DQDQWLELRWLFXVHGWRWUHDWXULQDU\WUDFWLQIHFWLRQV
Ě FLFORVSRULQ XVHGWRSUHYHQWUHMHFWLRQRIRUJDQVRUWLVVXHVIROORZLQJD
WUDQVSODQWRUWRWUHDWFHUWDLQVNLQFRQGLWLRQVOLNHSVRULDVLVDQGHF]HPDRU
WRWUHDWUKHXPDWRLGDUWKULWLV 
Having vaccines while you are taking Melphalan
,I\RXDUHJRLQJWRKDYHDYDFFLQDWLRQVSHDNWR\RXUGRFWRURUQXUVHEHIRUH
\RXKDYHLW7KLVLVEHFDXVHVRPHYDFFLQHV OLNHSROLRPHDVOHVPXPSVDQG
UXEHOOD PD\JLYH\RXDQLQIHFWLRQLI\RXKDYHWKHPZKLOVW\RXDUHEHLQJ
WUHDWHGZLWK0HOSKDODQ
Pregnancy and breast-feeding
'RQRWKDYH0HOSKDODQLI\RXDUHSODQQLQJWRKDYHDEDE\7KLVDSSOLHVWR
ERWKPHQDQGZRPHQ0HOSKDODQPD\KDUP\RXUVSHUPRUHJJV5HOLDEOH
FRQWUDFHSWLYHSUHFDXWLRQVPXVW EHWDNHQWRDYRLGSUHJQDQF\ZKLOVW\RXRU
\RXUSDUWQHUDUHKDYLQJWKLVLQMHFWLRQ$VN\RXUGRFWRUIRUDGYLFH
,I\RXDUHDOUHDG\SUHJQDQWLWLVLPSRUWDQWWRWDONWR\RXUGRFWRUEHIRUH
KDYLQJ0HOSKDODQ
'RQRWEUHDVWIHHGZKLOHKDYLQJ0HOSKDODQ$VN\RXUGRFWRURUPLGZLIHIRU
DGYLFH
3 How to have Melphalan
0HOSKDODQ VKRXOG RQO\ EH SUHVFULEHG IRU \RX E\ D VSHFLDOLVW GRFWRU ZKR LV
H[SHULHQFHGLQWUHDWLQJEORRGSUREOHPVRUFDQFHU
0HOSKDODQLQMHFWLRQFDQEHJLYHQ
Ě DVDQLQIXVLRQLQWR\RXUYHLQ
Ě DVDSHUIXVLRQWRDSDUWLFXODUSDUWRI\RXUERG\WKURXJKDQDUWHU\
0HOSKDODQGHSHQGVRQ
Ě \ RXUERG\ZHLJKWRUERG\VXUIDFHDUHD DVSHFLILFPHDVXUHPHQWWDNLQJLQWR
DFFRXQW\RXUZHLJKWDQG\RXUVL]H
Ě RWKHUGUXJV\RXDUHKDYLQJ
Ě \RXUGLVHDVH
Ě \RXUDJH
Ě ZKHWKHURUQRW\RXKDYHNLGQH\SUREOHPV
:KHQ\RXDUHJLYHQ0HOSKDODQ\RXUGRFWRUZLOOWDNHUHJXODUEORRGWHVWV7KLV
LV WR FKHFN WKH QXPEHU RI FHOOV LQ \RXU EORRG FKDQJH\RXUGRVHDVDUHVXOWRIWKHVHWHVWV

Soft tissue sarcoma: +\SHUWKHUPLFUHJLRQDOSHUIXVLRQZLWK0HOSKDODQKDV
EHHQXVHGLQWKHPDQDJHPHQWRIDOOVWDJHVRIORFDOLVHGVRIWWLVVXHVDUFRPD
XVXDOO\LQFRPELQDWLRQZLWKVXUJHU\0HOSKDODQKDVDOVREHHQJLYHQZLWK
DFWLQRP\FLQ'DQGWKHVFLHQWLILFOLWHUDWXUHVKRXOGEHFRQVXOWHGIRUGHWDLOV
RIGRVDJHUHJLPHQV$W\SLFDOGRVHUDQJHIRUXSSHUH[WUHPLW\SHUIXVLRQV
LVWRPJNJERG\ZHLJKWDQGIRUORZHUH[WUHPLW\SHUIXVLRQVLV
WRPJNJERG\ZHLJKW
Advanced neuroblastoma: 'RVHVRIEHWZHHQDQGPJPERG\
VXUIDFHDUHD VRPHWLPHVGLYLGHGHTXDOO\RYHUFRQVHFXWLYHGD\V WRJHWKHU
ZLWKDXWRORJRXVERQHPDUURZUHVFXHKDYHEHHQXVHGHLWKHUDORQHRULQ
FRPELQDWLRQZLWKUDGLRWKHUDS\DQGRURWKHUF\WRWR[LFGUXJV

Dosage and administration
0HOSKDODQLVDF\WRWR[LFGUXJZKLFKIDOOVLQWRWKHJHQHUDOFODVVRIDON\ODWLQJ
DJHQWV,WVKRXOGEHSUHVFULEHGRQO\E\SK\VLFLDQVH[SHULHQFHGLQWKH
PDQDJHPHQWRIPDOLJQDQWGLVHDVHZLWKVXFKDJHQWV
6LQFH0HOSKDODQLVP\HORVXSSUHVVLYHIUHTXHQWEORRGFRXQWVDUHHVVHQWLDO
GXULQJWKHUDS\DQGWKHGRVDJHVKRXOGEHGHOD\HGRUDGMXVWHGLIQHFHVVDU\
VHHPrecautionV 
Multiple myeloma: 0HOSKDODQ,QMHFWLRQKDVEHHQXVHGRQDQ
LQWHUPLWWHQWEDVLVDORQHRULQFRPELQDWLRQZLWKRWKHUF\WRWR[LFGUXJVDW
GRVHVYDU\LQJEHWZHHQPJPERG\VXUIDFHDUHDDQGPJPERG\
VXUIDFHDUHDJLYHQDWLQWHUYDOVRIEHWZHHQWRZHHNV$GGLWLRQDOO\
DGPLQLVWUDWLRQRISUHGQLVRQHKDVEHHQLQFOXGHGLQDQXPEHURIUHJLPHQV
7KHOLWHUDWXUHVKRXOGEHFRQVXOWHGIRUSUHFLVHGHWDLOVRQWUHDWPHQWSURWRFROV
:KHQXVHGDVDVLQJOHDJHQWDW\SLFDOLQWUDYHQRXVGRVDJHVFKHGXOH
LVPJNJERG\ZHLJKW PJPERG\VXUIDFHDUHD UHSHDWHGDW
DSSURSULDWHLQWHUYDOV HJRQFHHYHU\ZHHNV SURYLGHGWKHUHKDVEHHQ
UHFRYHU\RIWKHSHULSKHUDOEORRGFRXQWGXULQJWKLVSHULRG
+LJKGRVHUHJLPHQVJHQHUDOO\HPSOR\VLQJOHLQWUDYHQRXVGRVHVRI
EHWZHHQDQGPJPERG\VXUIDFHDUHD DSSUR[LPDWHO\WR
PJNJERG\ZHLJKW EXWDXWRORJRXVERQHPDUURZUHVFXHEHFRPHV
HVVHQWLDOIROORZLQJGRVHVLQH[FHVVRIPJPERG\VXUIDFHDUHD
,QFDVHVRIUHQDOLPSDLUPHQWWKHGRVHVKRXOGEHUHGXFHGE\ILIW\SHUFHQW
VHHDosage in renal impairmenW ,QYLHZRIWKHVHYHUHP\HORVXSSUHVVLRQ
LQGXFHGE\KLJKGRVH0HOSKDODQ,QMHFWLRQWUHDWPHQWVKRXOGEH
FRQILQHGWRVSHFLDOLVWFHQWUHVZLWKWKHDSSURSULDWHIDFLOLWLHVDQGRQO\EH
DGPLQLVWHUHGE\H[SHULHQFHGFOLQLFLDQV VHHPrecautionV 
Ovarian adenocarcinoma: :KHQXVHGLQWUDYHQRXVO\DVDVLQJOHDJHQWD
GRVHRIPJNJERG\ZHLJKW DSSUR[LPDWHO\PJPERG\VXUIDFHDUHD 
JLYHQDWLQWHUYDOVRIZHHNVKDVRIWHQEHHQXVHG
:KHQFRPELQHGZLWKRWKHUF\WRWR[LFGUXJVLQWUDYHQRXVGRVHVRIEHWZHHQ
DQGPJNJERG\ZHLJKW WRPJPERG\VXUIDFHDUHD KDYH
EHHQXVHGDWLQWHUYDOVRIWRZHHNV

Preparation of Melphalan Injection Solution: 0HOSKDODQ,QMHFWLRQVKRXOG
EHSUHSDUHG$752207(03(5$785(E\UHFRQVWLWXWLQJWKHIUHH]HGULHG
SRZGHUZLWKWKH6ROYHQW'LOXHQWSURYLGHG
PORIWKHYHKLFOHVKRXOGEHDGGHGTXLFNO\DVDVLQJOHTXDQWLW\LQWR
WKHYLDOFRQWDLQLQJWKHIUHH]HGULHGSRZGHUDQGLPPHGLDWHO\VKDNHQ
9,*25286/< IRUDWOHDVWVHFRQGV XQWLODFOHDUVROXWLRQZLWKRXWYLVLEOH
SDUWLFOHVLVREWDLQHG(DFKYLDOPXVWEHUHFRQVWLWXWHGLQGLYLGXDOO\LQWKLV
PDQQHU7KHUHVXOWLQJVROXWLRQFRQWDLQVWKHHTXLYDOHQWRIPJSHUPO
DQK\GURXVPHOSKDODQDQGKDVDS+RIDSSUR[LPDWHO\
0HOSKDODQ,QMHFWLRQVROXWLRQKDVOLPLWHGVWDELOLW\DQGVKRXOGEHSUHSDUHG
LPPHGLDWHO\EHIRUHXVH$Q\XQXVHGVROXWLRQUHPDLQLQJDIWHURQHKRXU
VKRXOGEHGLVFDUGHG(See Pharmaceutical precautions).
7KHUHFRQVWLWXWHGVROXWLRQVKRXOGQRWEHUHIULJHUDWHGDVWKLVZLOOFDXVH
SUHFLSLWDWLRQ
Parenteral administration: ([FHSWLQFDVHVZKHUHUHJLRQDODUWHULDO
SHUIXVLRQLVLQGLFDWHG0HOSKDODQ,QMHFWLRQLVIRULQWUDYHQRXVXVHRQO\
)RULQWUDYHQRXVDGPLQLVWUDWLRQLWLVUHFRPPHQGHGWKDW0HOSKDODQ,QMHFWLRQ
VROXWLRQLVLQMHFWHGVORZO\LQWRDIDVWUXQQLQJLQIXVLRQVROXWLRQYLDDVZDEEHG
LQMHFWLRQSRUW
,IGLUHFWLQMHFWLRQLQWRDIDVWUXQQLQJLQIXVLRQLVQRWDSSURSULDWH0HOSKDODQ
,QMHFWLRQVROXWLRQPD\EHDGPLQLVWHUHGGLOXWHGLQDQLQIXVLRQEDJ
0HOSKDODQLVQRWFRPSDWLEOHZLWKLQIXVLRQVROXWLRQVFRQWDLQLQJGH[WURVH
DQGLWLVUHFRPPHQGHGWKDW21/<6RGLXP&KORULGH,QWUDYHQRXV,QIXVLRQ
ZYLVXVHG
:KHQIXUWKHUGLOXWHGLQDQLQIXVLRQVROXWLRQ0HOSKDODQ,QMHFWLRQKDV
UHGXFHGVWDELOLW\DQGWKHUDWHRIGHJUDGDWLRQLQFUHDVHVUDSLGO\ZLWK
ULVHLQWHPSHUDWXUH,IDGPLQLVWUDWLRQRFFXUVDWDURRPWHPSHUDWXUHRI
DSSUR[LPDWHO\Ń&WKHWRWDOWLPHIURPSUHSDUDWLRQRIWKH,QMHFWLRQVROXWLRQ
WRWKHFRPSOHWLRQRILQIXVLRQVKRXOGQRWH[FHHGKRXUV
6KRXOGDQ\YLVLEOHWXUELGLW\RUFU\VWDOOL]DWLRQDSSHDULQWKHUHFRQVWLWXWHGRU
GLOXWHGVROXWLRQVWKHSUHSDUDWLRQPXVWEHGLVFDUGHG
&DUHVKRXOGEHWDNHQWRDYRLGSRVVLEOHH[WUDYDVDWLRQRI0HOSKDODQDQGLQ
FDVHVRISRRUSHULSKHUDOYHQRXVDFFHVVFRQVLGHUDWLRQVKRXOGEHJLYHQWRXVH
RIDFHQWUDOYHQRXVOLQH
,IKLJKGRVH0HOSKDODQ,QMHFWLRQLVDGPLQLVWHUHGZLWKRUZLWKRXWDXWRORJRXV
ERQHPDUURZWUDQVSODQWDWLRQDGPLQLVWUDWLRQYLDDFHQWUDOYHQRXVOLQHLV
UHFRPPHQGHG
)RUUHJLRQDODUWHULDOSHUIXVLRQWKHOLWHUDWXUHVKRXOGEHFRQVXOWHGIRUGHWDLOHG
PHWKRGRORJ\
Use in children: 0HOSKDODQDWFRQYHQWLRQDOGRVDJHLVRQO\UDUHO\LQGLFDWHG
LQFKLOGUHQDQGGRVDJHJXLGHOLQHVFDQQRWEHVWDWHG
+LJKGRVH0HOSKDODQ,QMHFWLRQLQDVVRFLDWLRQZLWKERQHPDUURZUHVFXHKDV
EHHQXVHGLQFKLOGKRRGQHXUREODVWRPDDQGGRVDJHJXLGHOLQHVEDVHGRQERG\
VXUIDFHDUHDDVIRUDGXOWVPD\EHXVHG
Use in the elderly: $OWKRXJK0HOSKDODQLVIUHTXHQWO\XVHGDWFRQYHQWLRQDO
GRVDJHLQWKHHOGHUO\WKHUHLVQRVSHFLILFLQIRUPDWLRQDYDLODEOHUHODWLQJWRLWV
DGPLQLVWUDWLRQWRWKLVSDWLHQWVXEJURXS
([SHULHQFHLQWKHXVHRIKLJKGRVH0HOSKDODQLQHOGHUO\SDWLHQWVLVOLPLWHG
&RQVLGHUDWLRQVKRXOGWKHUHIRUHEHJLYHQWRHQVXUHDGHTXDWHSHUIRUPDQFH
VWDWXVDQGRUJDQIXQFWLRQEHIRUHXVLQJKLJKGRVH0HOSKDODQ,QMHFWLRQLQ
HOGHUO\SDWLHQWV
Dosage in renal impairment: 0HOSKDODQFOHDUDQFHWKRXJKYDULDEOHLV
GHFUHDVHGLQUHQDOLPSDLUPHQW
:KHQ0HOSKDODQ,QMHFWLRQLVXVHGDWFRQYHQWLRQDOLQWUDYHQRXVGRVDJH
WRPJPERG\VXUIDFHDUHD LWLVUHFRPPHQGHGWKDWWKHLQLWLDOGRVH
VKRXOGEHUHGXFHGE\LQSDWLHQWVZLWKPRGHUDWHWRVHYHUHUHQDO
LPSDLUPHQWDQGVXEVHTXHQWGRVDJHGHWHUPLQHGDFFRUGLQJWRWKHGHJUHHRI
KDHPDWRORJLFDOVXSSUHVVLRQ
)RUKLJKLQWUDYHQRXVGRVHVRI0HOSKDODQ WRPJPERG\VXUIDFHDUHD 
WKHQHHGIRUGRVHUHGXFWLRQGHSHQGVXSRQWKHGHJUHHRIUHQDOLPSDLUPHQW
ZKHWKHUDXWRORJRXVERQHPDUURZVWHPFHOOVDUHUHLQIXVHGDQGWKHUDSHXWLF
QHHG$VDJXLGHIRUPRGHUDWHWRVHYHUHUHQDOLPSDLUPHQW ('7$FOHDUDQFHWR
POPLQ DGRVHUHGXFWLRQRILVXVXDO$GHTXDWHK\GUDWLRQDQGIRUFHG
GLXUHVLVDUHDOVRQHFHVVDU\+LJKGRVH0HOSKDODQLVQRWUHFRPPHQGHGLQSDWLHQWV
ZLWKPRUHVHYHUHUHQDOLPSDLUPHQW ('7$FOHDUDQFHOHVVWKDQPOPLQ 

Malignant melanoma: +\SHUWKHUPLFUHJLRQDOSHUIXVLRQZLWK0HOSKDODQ
KDVEHHQXVHGDVDQDGMXYDQWWRVXUJHU\IRUHDUO\PDOLJQDQWPHODQRPDDQG
DVSDOOLDWLYHWUHDWPHQWIRUDGYDQFHGEXWORFDOLVHGGLVHDVH7KHVFLHQWLILF
OLWHUDWXUHVKRXOGEHFRQVXOWHGIRUGHWDLOVRISHUIXVLRQWHFKQLTXHDQGGRVDJH
XVHG$W\SLFDOGRVHUDQJHIRUXSSHUH[WUHPLW\SHUIXVLRQVLVWRPJNJ
ERG\ZHLJKWDQGIRUORZHUH[WUHPLW\SHUIXVLRQVLVWRPJNJERG\
ZHLJKW

Contra-indications, warnings, etc
Contra-indications: 0HOSKDODQVKRXOGQRWEHJLYHQWRSDWLHQWVZKRKDYH
VXIIHUHGDSUHYLRXVK\SHUVHQVLWLYLW\UHDFWLRQWRPHOSKDODQ
 
Precautions: 0(/3+$/$1,6$1$&7,9(&<7272;,&$*(17)25
  
86(81'(57+(',5(&7,212)3+<6,&,$16(;3(5,(1&(',17+(
$'0,1,675$7,212)68&+$*(176
,PPXQLVDWLRQXVLQJDOLYHRUJDQLVPYDFFLQHKDVWKHSRWHQWLDOWRFDXVH

To the Medical and Pharmaceutical Professions
Presentation
0HOSKDODQ,QMHFWLRQLVVXSSOLHGDVDXQLWSDFNFRPSULVLQJDYLDOFRQWDLQLQJD
IUHH]HGULHGSRZGHUDQGDYLDORIVROYHQWGLOXHQW(DFK0HOSKDODQYLDOFRQWDLQV
WKHHTXLYDOHQWRIPJRIPHOSKDODQLQWKHIRUPRIWKHK\GURFKORULGHDVD
VWHULOHZKLWHWRRIIZKLWHIUHH]HGULHGSRZGHUZKLFKLQFOXGHVPJSRYLGRQH
.(DFKYLDORIVROYHQWGLOXHQWSURYLGHVPORIEXIIHUVROXWLRQFRQWDLQLQJ
YYSURS\OHQHJO\FROZLWKVRGLXPFLWUDWHDQGHWKDQRO
Uses
0HOSKDODQ,QMHFWLRQDGPLQLVWHUHGE\UHJLRQDODUWHULDOSHUIXVLRQLVLQGLFDWHG
LQWKHWUHDWPHQWRIORFDOLVHGPDOLJQDQWPHODQRPDRIWKHH[WUHPLWLHVDQG
ORFDOLVHGVRIWWLVVXHVDUFRPDRIWKHH[WUHPLWLHV
0HOSKDODQ,QMHFWLRQDWFRQYHQWLRQDOLQWUDYHQRXVGRVDJHPD\EHXVHGLQWKH
WUHDWPHQWRI
multiple myeloma: 0HOSKDODQ,QMHFWLRQHLWKHUDORQHRULQFRPELQDWLRQ
ZLWKRWKHUF\WRWR[LFGUXJVLVDVHIIHFWLYHDVWKHRUDOIRUPXODWLRQLQWKH
WUHDWPHQWRIPXOWLSOHP\HORPD
ovarian cancer: 0HOSKDODQ,QMHFWLRQSURGXFHVDQREMHFWLYHUHVSRQVH
LQDSSUR[LPDWHO\ILIW\SHUFHQWRIWKHSDWLHQWVZLWKDGYDQFHGRYDULDQ
DGHQRFDUFLQRPDZKHQJLYHQDORQHRULQFRPELQDWLRQZLWKRWKHUF\WRWR[LFGUXJV
0HOSKDODQ,QMHFWLRQDWKLJKLQWUDYHQRXVGRVDJHPD\EHXVHGLQWKHWUHDWPHQWRI
multiple myeloma: FRPSOHWHUHPLVVLRQVKDYHEHHQDFKLHYHGLQXSWR
ILIW\SHUFHQWRISDWLHQWVJLYHQKLJKGRVH0HOSKDODQ,QMHFWLRQZLWKRU
ZLWKRXWDXWRORJRXVERQHPDUURZUHVFXHHLWKHUDVILUVWOLQHWUHDWPHQWRUWR
FRQVROLGDWHDUHVSRQVHWRFRQYHQWLRQDOF\WRUHGXFWLYHFKHPRWKHUDS\
neuroblastoma in childhood: KLJKGRVH0HOSKDODQ,QMHFWLRQZLWK
DXWRORJRXVERQHPDUURZUHVFXHKDVEHHQXVHGHLWKHUDORQHRUFRPELQHG
ZLWKUDGLRWKHUDS\DQGRURWKHUF\WRWR[LFGUXJVWRFRQVROLGDWHDUHVSRQVHWR
FRQYHQWLRQDOWUHDWPHQW$VLJQLILFDQWLQFUHDVHLQWKHGXUDWLRQRIGLVHDVHIUHH
VXUYLYDOZDVGHPRQVWUDWHGLQDSURVSHFWLYHUDQGRPLVHGWULDORIKLJKGRVH
0HOSKDODQ,QMHFWLRQYHUVXVQRIXUWKHUWUHDWPHQW

If you have more Melphalan than you need
PXFK,I\RXWKLQN\RXKDYHEHHQJLYHQWRRPXFKRUKDYHPLVVHGDGRVHWHOO
\RXUGRFWRURUQXUVH
4 Possible side effects
/LNHDOOPHGLFLQHV0HOSKDODQFDQFDXVHVLGHHIIHFWVDOWKRXJKQRWHYHU\ERG\
JHWVWKHP
If you get any of the following, talk to your specialist doctor or go to
hospital straight away:
Ě DOOHUJLFUHDFWLRQWKHVLJQVPD\LQFOXGH
  DUDVKOXPSVRUKLYHVRQWKHVNLQ
  VZROOHQIDFHH\HOLGVRUOLSV
  VXGGHQZKHH]LQHVVDQGWLJKWQHVVRIWKHFKHVW
  FROODSVH GXHWRFDUGLDFDUUHVW
Ě DQ\VLJQVRIIHYHURULQIHFWLRQ VRUHWKURDWVRUHPRXWKRUXULQDU\SUREOHPV
Ě DQ\unexpectedEUXLVLQJRUEOHHGLQJRUIHHOLQJH[WUHPHO\WLUHGGL]]\RU
EUHDWKOHVVDVWKLVFRXOGPHDQWKDWWRRIHZEORRGFHOOVRIDSDUWLFXODUW\SH
DUHEHLQJSURGXFHG
Ě LI\RXsuddenlyIHHOXQZHOO HYHQZLWKDQRUPDOWHPSHUDWXUH
Ě LI\RXUPXVFOHVDUHDFK\VWLIIRUZHDNand\RXUXULQHLVGDUNHUWKDQXVXDO
RUEURZQRUUHGLQFRORXUĘZKHQ\RXKDYH0HOSKDODQGLUHFWO\LQWR\RXU
DUPRUOHJ
7DONWR\RXUGRFWRULI\RXKDYHDQ\RIWKHIROORZLQJVLGHHIIHFWVZKLFKPD\
DOVRKDSSHQZLWKWKLVPHGLFLQH
Very common (affects more than 1 in 10 people)
Ě DGURSLQWKHQXPEHURIEORRGFHOOVDQGSODWHOHWV
Ě IHHOLQJVLFN QDXVHD EHLQJVLFN YRPLWLQJ DQGGLDUUKRHD
Ě PRXWKXOFHUVZLWKKLJKGRVHVRI0HOSKDODQ
Ě KDLUORVVZLWKKLJKGRVHVRI0HOSKDODQ
Ě DWLQJOLQJRUZDUPIHHOLQJZKHUH0HOSKDODQZDVLQMHFWHG
Ě SUREOHPVZLWK\RXUPXVFOHVOLNHZDVWLQJDQGDFKLQJĘZKHQ\RXKDYH
0HOSKDODQGLUHFWO\LQWR\RXUDUPRUOHJ
Common (affects less than 1 in 10 people)
Ě KDLUORVVZLWKXVXDOGRVHVRI0HOSKDODQ
Ě KLJKOHYHOVRIDFKHPLFDOFDOOHGXUHDLQ\RXUEORRGĘLQSHRSOHZLWKNLGQH\
SUREOHPVZKRDUHEHLQJWUHDWHGIRUP\HORPD
Ě DPXVFOHSUREOHPZKLFKFDQFDXVHSDLQWLJKWQHVVWLQJOLQJEXUQLQJRU
QXPEQHVVĘFDOOHGFRPSDUWPHQWV\QGURPH7KLVFDQKDSSHQZKHQ\RX
KDYH0HOSKDODQGLUHFWO\LQWR\RXUDUPRUOHJ
Rare (affects less than 1 in 1,000 people)
Ě DQLOOQHVVZKHUH\RXKDYHDORZQXPEHURIUHGEORRGFHOOVDVWKH\DUH
EHLQJGHVWUR\HGSUHPDWXUHO\ĘWKLVFDQPDNH\RXIHHOYHU\WLUHGEUHDWKOHVV
DQGGL]]\DQGFDQJLYH\RXKHDGDFKHVRUPDNH\RXUVNLQRUH\HV\HOORZ
Ě OXQJSUREOHPVZKLFKPD\PDNH\RXFRXJKRUZKHH]HDQGPDNHLWGLIILFXOW
WREUHDWKH
Ě OLYHUSUREOHPVZKLFKPD\VKRZXSLQ\RXUEORRGWHVWVRUFDXVHMDXQGLFH
\HOORZLQJRIWKHZKLWHVRIH\HVDQGVNLQ
Ě PRXWKXOFHUVĘZLWKQRUPDOGRVHVRI0HOSKDODQ
Ě VNLQUDVKHVRULWFKLQJVNLQ

LQIHFWLRQLQLPPXQRFRPSURPLVHGKRVWV7KHUHIRUHLPPXQLVDWLRQVZLWKOLYH
RUJDQLVPYDFFLQHVDUHQRWUHFRPPHQGHG
0HOSKDODQ,QMHFWLRQVROXWLRQPD\FDXVHORFDOWLVVXHGDPDJHVKRXOG
H[WUDYDVDWLRQRFFXUDQGFRQVHTXHQWO\LWVKRXOGQRWEHDGPLQLVWHUHGE\GLUHFW
LQMHFWLRQLQWRDSHULSKHUDOYHLQ,WLVUHFRPPHQGHGWKDW0HOSKDODQ,QMHFWLRQ
VROXWLRQLVDGPLQLVWHUHGE\LQMHFWLQJVORZO\LQWRDIDVWUXQQLQJLQWUDYHQRXV
LQIXVLRQYLDDVZDEEHGLQMHFWLRQSRUWRUYLDDFHQWUDOYHQRXVOLQH
,QYLHZRIWKHKD]DUGVLQYROYHGDQGWKHOHYHORIVXSSRUWLYHFDUHUHTXLUHG
WKHDGPLQLVWUDWLRQRIKLJKGRVH0HOSKDODQ,QMHFWLRQVKRXOGEHFRQILQHGWR
VSHFLDOLVWFHQWUHVZLWKWKHDSSURSULDWHIDFLOLWLHVDQGRQO\EHFRQGXFWHGE\
H[SHULHQFHGFOLQLFLDQV
,QSDWLHQWVUHFHLYLQJKLJKGRVH0HOSKDODQ,QMHFWLRQFRQVLGHUDWLRQVKRXOG
EHJLYHQWRWKHSURSK\ODFWLFDGPLQLVWUDWLRQRIDQWLLQIHFWLYHDJHQWVWKH
DGPLQLVWUDWLRQRIEORRGSURGXFWVDVUHTXLUHGDQGWKHPDLQWHQDQFHRIDKLJK
UHQDORXWSXWGXULQJWKHSHULRGLPPHGLDWHO\IROORZLQJWKHDGPLQLVWUDWLRQRI
0HOSKDODQE\WKHXVHRIK\GUDWLRQDQGIRUFHGGLXUHVLV
&RQVLGHUDWLRQVKRXOGEHJLYHQWRHQVXUHDGHTXDWHSHUIRUPDQFHVWDWXVDQG
RUJDQIXQFWLRQEHIRUHXVLQJKLJKGRVH0HOSKDODQ,QMHFWLRQ
Safe handling of Melphalan: 7KHKDQGOLQJRI0HOSKDODQIRUPXODWLRQV
VKRXOGIROORZJXLGHOLQHVIRUWKHKDQGOLQJRIF\WRWR[LFGUXJVDFFRUGLQJWRWKH
5R\DO3KDUPDFHXWLFDO6RFLHW\RI*UHDW%ULWDLQ:RUNLQJ3DUW\RQWKH+DQGOLQJ
RI&\WRWR[LF'UXJV
Monitoring: 6LQFH0HOSKDODQLVDSRWHQWP\HORVXSSUHVVLYHDJHQWLWLV
HVVHQWLDOWKDWFDUHIXODWWHQWLRQVKRXOGEHSDLGWRWKHPRQLWRULQJRIEORRG
FRXQWVWRDYRLGWKHSRVVLELOLW\RIH[FHVVLYHP\HORVXSSUHVVLRQDQGWKHULVN
RILUUHYHUVLEOHERQHPDUURZDSODVLD%ORRGFRXQWVPD\FRQWLQXHWRIDOO
DIWHUWUHDWPHQWLVVWRSSHGVRDWWKHILUVWVLJQRIDQDEQRUPDOO\ODUJHIDOOLQ
OHXNRF\WHRUSODWHOHWFRXQWVWUHDWPHQWVKRXOGEHWHPSRUDULO\LQWHUUXSWHG
0HOSKDODQVKRXOGEHXVHGZLWKFDXWLRQLQSDWLHQWVZKRKDYHXQGHUJRQH
UHFHQWUDGLRWKHUDS\RUFKHPRWKHUDS\LQYLHZRILQFUHDVHGERQHPDUURZ
WR[LFLW\
Renal impairment: 0HOSKDODQFOHDUDQFHPD\EHUHGXFHGLQSDWLHQWVZLWK
UHQDOLPSDLUPHQWZKRPD\DOVRKDYHXUDHPLFERQHPDUURZVXSSUHVVLRQ
'RVHUHGXFWLRQPD\WKHUHIRUHEHQHFHVVDU\ VHHDosage and administratioQ 
DQGWKHVHSDWLHQWVVKRXOGEHFORVHO\REVHUYHG 6HHSide and adverse effects
IRUHOHYDWLRQRIEORRGXUHD 
Mutagenicity: 0HOSKDODQLVPXWDJHQLFLQDQLPDOVDQGFKURPRVRPH
DEHUUDWLRQVKDYHEHHQREVHUYHGLQSDWLHQWVEHLQJWUHDWHGZLWKWKHGUXJ
Carcinogenicity: 0HOSKDODQLQFRPPRQZLWKRWKHUDON\ODWLQJDJHQWV
KDVEHHQUHSRUWHGWREHOHXNDHPRJHQLF7KHUHKDYHEHHQUHSRUWVRIDFXWH
OHXNDHPLDRFFXUULQJDIWHUPHOSKDODQWUHDWPHQWIRUGLVHDVHVVXFKDV
DP\ORLGPDOLJQDQWPHODQRPDPXOWLSOHP\HORPDPDFURJOREXOLQDHPLDFROG
DJJOXWLQLQV\QGURPHDQGRYDULDQFDQFHU
$FRPSDULVRQRISDWLHQWVZLWKRYDULDQFDQFHUZKRUHFHLYHGDON\ODWLQJDJHQWV
ZLWKWKRVHZKRGLGQRWVKRZHGWKDWWKHXVHRIDON\ODWLQJDJHQWVLQFOXGLQJ
PHOSKDODQVLJQLILFDQWO\LQFUHDVHGWKHLQFLGHQFHRIDFXWHOHXNDHPLD
7KHOHXNDHPRJHQLFULVNPXVWEHEDODQFHGDJDLQVWWKHSRWHQWLDOWKHUDSHXWLF
EHQHILWZKHQFRQVLGHULQJWKHXVHRIPHOSKDODQ
Effects on fertility: 0HOSKDODQFDXVHVVXSSUHVVLRQRIRYDULDQIXQFWLRQLQ
SUHPHQRSDXVDOZRPHQUHVXOWLQJLQDPHQRUUKRHDLQDVLJQLILFDQWQXPEHURI
SDWLHQWV
7KHUHLVHYLGHQFHIURPVRPHDQLPDOVWXGLHVWKDW0HOSKDODQFDQKDYHDQ
DGYHUVHHIIHFWRQVSHUPDWRJHQHVLV7KHUHIRUHLWLVSRVVLEOHWKDW0HOSKDODQ
PD\FDXVHWHPSRUDU\RUSHUPDQHQWVWHULOLW\LQPDOHSDWLHQWV
Use in pregnancy and lactation: 7KHWHUDWRJHQLFSRWHQWLDORI0HOSKDODQ
KDVQRWEHHQVWXGLHG,QYLHZRILWVPXWDJHQLFSURSHUWLHVDQGVWUXFWXUDO
VLPLODULW\WRNQRZQWHUDWRJHQLFFRPSRXQGVLWLVSRVVLEOHWKDWPHOSKDODQ
FRXOGFDXVHFRQJHQLWDOGHIHFWVLQWKHRIIVSULQJRISDWLHQWVWUHDWHGZLWKWKH
GUXJ
$VZLWKDOOF\WRWR[LFFKHPRWKHUDS\DGHTXDWHFRQWUDFHSWLYHSUHFDXWLRQV
VKRXOGEHSUDFWLVHGZKHQHLWKHUSDUWQHULVUHFHLYLQJ0HOSKDODQ
7KHXVHRIPHOSKDODQVKRXOGEHDYRLGHGZKHQHYHUSRVVLEOHGXULQJ
SUHJQDQF\SDUWLFXODUO\GXULQJWKHILUVWWULPHVWHU,QDQ\LQGLYLGXDOFDVHWKH
SRWHQWLDOKD]DUGWRWKHIRHWXVPXVWEHEDODQFHGDJDLQVWWKHH[SHFWHGEHQHILW
WRWKHPRWKHU
0RWKHUVUHFHLYLQJ0HOSKDODQVKRXOGQRWEUHDVWIHHG
Side and adverse effects: 8QGHVLUDEOHHIIHFWVPD\YDU\LQWKHLULQFLGHQFH
GHSHQGLQJRQWKHLQGLFDWLRQDQGGRVHUHFHLYHGDQGDOVRZKHQJLYHQLQ
FRPELQDWLRQZLWKRWKHUWKHUDSHXWLFDJHQWV&ODVVLILFDWLRQRIIUHTXHQF\9HU\
FRPPRQĽFRPPRQĽXQFRPPRQĽDQG
UDUHĽDQGYHU\UDUH
Ě Blood and lymphatic system disordersYHU\FRPPRQERQHPDUURZ
GHSUHVVLRQOHDGLQJWROHXFRSHQLDWKURPERF\WRSHQLDDQDHPLDUDUH
KDHPRO\WLFDQDHPLD
Ě Immune system disordersUDUHDOOHUJLFUHDFWLRQVXUWLFDULDRHGHPD
VNLQUDVKHVDQGDQDSK\ODFWLFVKRFNKDYHEHHQUHSRUWHGXQFRPPRQO\
IROORZLQJLQLWLDORUVXEVHTXHQWGRVLQJSDUWLFXODUO\DIWHULQWUDYHQRXV
DGPLQLVWUDWLRQ&DUGLDFDUUHVWKDVDOVREHHQUHSRUWHGUDUHO\LQDVVRFLDWLRQ
ZLWKVXFKHYHQWV
Ě Respiratory, thoracic and mediastinal disordersUDUHLQWHUVWLWLDO
SQHXPRQLWLVDQGSXOPRQDU\ILEURVLV LQFOXGLQJIDWDOUHSRUWV 
Ě Gastrointestinal disordersYHU\FRPPRQQDXVHDYRPLWLQJDQG
GLDUUKRHDVWRPDWLWLVDWKLJKGRVHUDUHVWRPDWLWLVDWFRQYHQWLRQDO
GRVH,QFLGHQFHRIGLDUUKRHDYRPLWLQJDQGVWRPDWLWLVEHFRPHVWKH
GRVHOLPLWLQJWR[LFLW\LQSDWLHQWVJLYHQKLJKLQWUDYHQRXVGRVHVRI
PHOSKDODQLQDVVRFLDWLRQZLWKDXWRORJRXVERQHPDUURZWUDQVSODQWDWLRQ
&\FORSKRVSKDPLGHSUHWUHDWPHQWDSSHDUVWRUHGXFHWKHVHYHULW\&RQVXOW
WKHOLWHUDWXUHIRUGHWDLOV

7KHIROORZLQJVLGHHIIHFWVDOVRKDSSHQZLWK0HOSKDODQ
Ě OHXNDHPLDĘFDQFHURIWKHEORRG
Ě LQZRPHQ\RXUSHULRGVVWRSSLQJ
,IDQ\RIWKHVLGHHIIHFWVJHWVVHULRXVRULI\RXQRWLFHDQ\VLGHHIIHFWVQRW
OLVWHGLQWKLVOHDIOHWSOHDVHWHOO\RXUGRFWRURUSKDUPDFLVW
5 How to store Melphalan
Ě .HHSRXWRIWKHUHDFKDQGVLJKWRIFKLOGUHQ
Ě 'RQRWXVH0HOSKDODQDIWHUWKHH[SLU\GDWHZKLFKLVVWDWHGRQWKHSDFN
DIWHUĎ([Sď
Ě 'RQRWVWRUH0HOSKDODQ,QMHFWLRQDERYHŃ&'RQRWUHIULJHUDWH.HHSWKH
YLDOLQWKHRXWHUFDUWRQWRSURWHFWIURPOLJKW
Ě  SURIHVVLRQDO2QFHSUHSDUHGLWVKRXOGEHXVHGLPPHGLDWHO\DQGPXVWQRW
EHVWRUHGRUUHIULJHUDWHG
6 Further information
What Melphalan contains
7KHDFWLYHLQJUHGLHQWLVPHOSKDODQ(DFK0HOSKDODQLQMHFWLRQFRQWDLQVPJ
RIPHOSKDODQ
7KHRWKHULQJUHGLHQWVDUHSRYLGRQH.DQGK\GURFKORULFDFLG0HOSKDODQ
LVGLVVROYHGLQDGLOXHQWEHIRUHEHLQJLQMHFWHG7KHGLOXHQWFRQWDLQVZDWHU
VRGLXPFLWUDWHSURS\OHQHJO\FRODQGHWKDQRO
What Melphalan looks like and contents of the pack
(DFKSDFNFRQWDLQVRQH0HOSKDODQ,QMHFWLRQYLDODQGRQH0HOSKDODQ
,QMHFWLRQ'LOXHQWYLDO
Marketing Authorisation Holder and Manufacturer
0DUNHWLQJ$XWKRULVDWLRQKROGHU
$VSHQ3KDUPD7UDGLQJ/LPLWHG
/DNH'ULYH
&LW\ZHVW%XVLQHVV&DPSXV
'XEOLQ,UHODQG
0DQXIDFWXUHU*OD[R6PLWK.OLQH0DQXIDFWXULQJ6S$6DQ3RORGL7RUULOH
3DUPD,WDO\
Other formats:
7ROLVWHQWRRUUHTXHVWDFRS\RIWKLVOHDIOHWLQ%UDLOOHODUJHSULQWRUDXGLR
SOHDVHFDOOIUHHRIFKDUJH
 8.RQO\ 
3OHDVHEHUHDG\WRJLYHWKHIROORZLQJLQIRUPDWLRQ
Product name Melphalan 50 mg Powder and Solvent for Solution for
Injection/Infusion.5HIHUHQFHQXPEHU3/
7KLVLVDVHUYLFHSURYLGHGE\WKH5R\DO1DWLRQDO,QVWLWXWHRIWKH%OLQG
/HDIOHWGDWH
 
  

Ě Hepatobiliary disordersUDUHKHSDWLFGLVRUGHUVUDQJLQJIURPDEQRUPDO
OLYHUIXQFWLRQWHVWVWRFOLQLFDOPDQLIHVWDWLRQVVXFKDVKHSDWLWLVDQG
MDXQGLFHYHQRRFFOXVLYHGLVHDVHIROORZLQJKLJKGRVHWUHDWPHQW
Ě Skin and subcutaneous tissue disordersYHU\FRPPRQDORSHFLDDW
KLJKGRVHFRPPRQDORSHFLDDWFRQYHQWLRQDOGRVHUDUHPDFXORSDSXODU
UDVKHVDQGSUXULWXV
Ě Musculoskeletal and connective tissue disorders,QMHFWLRQIROORZLQJ
LVRODWHGOLPESHUIXVLRQYHU\FRPPRQPXVFOHDWURSK\PXVFOHILEURVLV
P\DOJLDEORRGFUHDWLQHSKRVSKRNLQDVHLQFUHDVHGFRPPRQFRPSDUWPHQW
V\QGURPHLQFLGHQFHQRWNQRZQPXVFOHQHFURVLVUKDEGRP\RO\VLV
Ě Renal and urinary disordersFRPPRQWHPSRUDU\VLJQLILFDQWHOHYDWLRQ
RIWKHEORRGXUHDKDVEHHQVHHQLQWKHHDUO\VWDJHVRIPHOSKDODQWKHUDS\
LQP\HORPDSDWLHQWVZLWKUHQDOGDPDJH
Ě General disorders and administration site conditionsYHU\FRPPRQ
VXEMHFWLYHDQGWUDQVLHQWVHQVDWLRQRIZDUPWKDQGRUWLQJOLQJ
Drug interactions: 1DOLGL[LFDFLGWRJHWKHUZLWKKLJKGRVHLQWUDYHQRXV
PHOSKDODQKDVFDXVHGGHDWKVLQFKLOGUHQGXHWRKDHPRUUKDJLFHQWHURFROLWLV
,PSDLUHGUHQDOIXQFWLRQKDVEHHQGHVFULEHGLQERQHPDUURZWUDQVSODQW
SDWLHQWVZKRZHUHFRQGLWLRQHGZLWKKLJKGRVHLQWUDYHQRXVPHOSKDODQDQG
ZKRVXEVHTXHQWO\UHFHLYHGFLFORVSRULQWRSUHYHQWJUDIWYHUVXVKRVWGLVHDVH
Toxicity and treatment of overdosage: 7KHLPPHGLDWHHIIHFWVRIDFXWH
LQWUDYHQRXVRYHUGRVDJHDUHQDXVHDDQGYRPLWLQJ'DPDJHWRWKHJDVWUR
LQWHVWLQDOPXFRVDPD\DOVRHQVXHDQGGLDUUKRHDVRPHWLPHVKDHPRUUKDJLF
KDVEHHQUHSRUWHGDIWHURYHUGRVDJH7KHSULQFLSDOWR[LFHIIHFWLVERQHPDUURZ
VXSSUHVVLRQOHDGLQJWROHXFRSHQLDWKURPERF\WRSHQLDDQGDQDHPLD
*HQHUDOVXSSRUWLYHPHDVXUHVWRJHWKHUZLWKDSSURSULDWHEORRGDQGSODWHOHW
WUDQVIXVLRQVVKRXOGEHLQVWLWXWHGLIQHFHVVDU\DQGFRQVLGHUDWLRQJLYHQWR
KRVSLWDOLVDWLRQDQWLELRWLFFRYHUDQGWKHXVHRIKDHPDWRORJLFDOJURZWK
IDFWRUV
7KHUHLVQRVSHFLILFDQWLGRWH7KHEORRGSLFWXUHVKRXOGEHFORVHO\PRQLWRUHG
IRUDWOHDVWIRXUZHHNVIROORZLQJRYHUGRVDJHXQWLOWKHUHLVHYLGHQFHRI
UHFRYHU\
Pharmaceutical precautions
Injection unit pack: 6WRUHEHORZŃ&3URWHFWIURPOLJKW'RQRWUHIULJHUDWH
0HOSKDODQ,QMHFWLRQVXUSOXVWRUHTXLUHPHQWVVKRXOGEHGHVWUR\HGLQD
PDQQHUDSSURSULDWHWRWKHSUHYDLOLQJORFDOUHJXODWRU\UHTXLUHPHQWVIRUWKH
GLVSRVDORIF\WRWR[LFGUXJV
Legal category
320
Package quantities
Injection unit pack: 9LDORI0HOSKDODQIUHH]HGULHGSRZGHUDQGYLDORI
VROYHQWGLOXHQW
Further information
1LO
Product licence numbers
Injection: 3/
Solvent-Diluent:3/
7KHOHDIOHWZDVODVWUHYLVHGLQ

 
  



+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide